Cited by 187Tuberculosis Research and EpidemiologyBacterial Genetics and BiotechnologyMycobacterium research and diagnosis

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Deletion of a mycobacterial divisome factor collapses single-cell phenotypic heterogeneity

Open access

Abstract

Microorganisms are often studied as populations but the behaviour of single, individual cells can have important consequences. For example, tuberculosis, caused by the bacterial pathogen Mycobacterium tuberculosis, requires months of antibiotic therapy even though the bulk of the bacterial population dies rapidly. Shorter courses lead to high rates of relapse because subpopulations of bacilli can survive despite being genetically identical to those that are easily killed. In fact, mycobacteria create variability each time a cell divides, producing daughter cells with different sizes and growth rates. The mechanism(s) that underlie this high-frequency variation and how variability relates to survival of the population are unknown. Here we show that mycobacteria actively create heterogeneity. Using a fluorescent reporter and a fluorescence-activated cell sorting (FACS)-based transposon screen, we find that deletion of lamA, a gene of previously unknown function, decreases heterogeneity in the population by decreasing asymmetric polar growth. LamA has no known homologues in other organisms, but is highly conserved across mycobacterial species. We find that LamA is a member of the mycobacterial division complex (the 'divisome'). It inhibits growth at nascent new poles, creating asymmetry in polar growth. The kinetics of killing individual cells that lack lamA are more uniform and more rapid with rifampicin and drugs that target the cell wall. Our results show that mycobacteria encode a non-conserved protein that controls the pattern of cell growth, resulting in a population that is both heterogeneous and better able to survive antibiotic pressure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature22361

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 22 references

Cited by

Sorted by citations

Items 101–187 of 187

Metadata

Authors
Rego, E. H., Audette, R. E., & Rubin, E. J.
Affiliations
Harvard University (US)
Corresponding author
  • Rego, E. Hesper
  • Rubin, Eric J.
Venue
Nature
Published
2017-05-31
Volume
546
Issue
7656
Pages
153-157
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2617852583
Cited by
186
References
22
Citations by year
2026: 14 · 2025: 15 · 2024: 18 · 2023: 16 · 2022: 23 · 2021: 16 · 2020: 25 · 2019: 22 · 2018: 30 · 2017: 7
FWCI
17.68
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
National Institute of Allergy and Infectious Diseases (U19AI107774, F32AI104287)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
Keywords
lamas, divisome, Mycobacterium tuberculosis, cell wall synthesis inhibition, cell division, phenotypic heterogeneity, antibiotic tolerance, rifampicin, tuberculosis drug targets, single-cell heterogeneity
MeSH terms
Anti-Bacterial Agents, Bacterial Proteins, Cell Division, Cell Wall, DNA Mutational Analysis, Flow Cytometry, Fluoresceins, Phenotype, Rifampin, Reproducibility of Results, Cell Polarity, Gene Deletion, Mycobacterium smegmatis, Microbial Viability, Single-Cell Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review